(Q37878487)

24 August 2017

1 reference

title

An update on vaccination against group B streptococcus (English)

1 reference

24 August 2017

Paul T Heath

1

0 references

publication date

1 May 2011

1 reference

Expert Review of Vaccines

24 August 2017

published in

1 reference

24 August 2017

volume

10

1 reference

24 August 2017

issue

5

1 reference

24 August 2017

page(s)

685-694

1 reference

Increasing Burden of Invasive Group B Streptococcal Disease in Nonpregnant Adults, 1990–2007

24 August 2017

cites work

1 reference

Group B streptococcal disease in UK and Irish infants younger than 90 days

21 January 2018

1 reference

Group B streptococcal disease in infants: a case control study.

21 January 2018

1 reference

High burden of invasive Streptococcus agalactiae disease in South African infants

21 January 2018

1 reference

Bacteremia among children admitted to a rural hospital in Kenya.

21 January 2018

1 reference

Invasive group B streptococcal infection in infants, Malawi

21 January 2018

1 reference

Meningitis in infancy in England and Wales: follow up at age 5 years

21 January 2018

1 reference

Early onset group B streptococcal neonatal infection in Oxford 1985-96.

21 January 2018

1 reference

Early-onset neonatal group B streptococcal infection in London: 1990-1999.

21 January 2018

1 reference

21 January 2018

Group B streptococcus

1 reference

Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005

21 January 2018

1 reference

Characterization of group B streptococci recovered from infants with invasive disease in England and Wales

21 January 2018

1 reference

Missed opportunities for preventing group B streptococcus infection

21 January 2018

1 reference

Early-onset group B streptococcal disease in the era of maternal screening

21 January 2018

1 reference

Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants

21 January 2018

1 reference

Revisiting the Need for Vaccine Prevention of Late-Onset Neonatal Group B Streptococcal Disease

21 January 2018

1 reference

Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection

21 January 2018

1 reference

Identification of a universal Group B streptococcus vaccine by multiple genome screen

21 January 2018

1 reference

Immunization with C5a peptidase or peptidase-type III polysaccharide conjugate vaccines enhances clearance of group B Streptococci from lungs of infected mice

21 January 2018

1 reference

Identification of group B streptococcal Sip protein, which elicits cross-protective immunity

21 January 2018

1 reference

Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm

21 January 2018

1 reference

Vaccination against group B streptococcus

21 January 2018

1 reference

TWO SEROLOGICAL TYPES OF GROUP B HEMOLYTIC STREPTOCOCCI WITH RELATED, BUT NOT IDENTICAL, TYPE-SPECIFIC SUBSTANCES.

21 January 2018

1 reference

Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine

21 January 2018

1 reference

Group B streptococcal conjugate vaccines

21 January 2018

1 reference

Conjugate vaccines against group B Streptococcus types IV and VII.

21 January 2018

1 reference

Synthesis and preclinical evaluation of glycoconjugate vaccines against group B Streptococcus types VI and VIII.

21 January 2018

1 reference

Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women

21 January 2018

1 reference

Use of type V group B streptococcal conjugate vaccine in adults 65-85 years old.

21 January 2018

1 reference

Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines

21 January 2018

1 reference

Safety and immunogenicity of a tetravalent group B streptococcal polysaccharide vaccine in healthy adults

21 January 2018

1 reference

Effects of alum adjuvant or a booster dose on immunogenicity during clinical trials of group B streptococcal type III conjugate vaccines

21 January 2018

1 reference

Prematurity is the major risk factor for late-onset group B streptococcus disease

21 January 2018

1 reference

Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity

21 January 2018

1 reference

Prevention of Haemophilus influenzae type b colonization by vaccination: correlation with serum anti-capsular IgG concentration

21 January 2018

1 reference

Neither antibody to a group B streptococcal conjugate vaccine nor the vaccine itself is teratogenic in rabbits

21 January 2018

1 reference

Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story

21 January 2018

1 reference

Immunization of pregnant women: reproductive, medical and societal risks

21 January 2018

1 reference

Serotype distribution of invasive group B streptococcal isolates in infants: results from a nationwide active laboratory surveillance study over 2 years in Germany

21 January 2018

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1086/427942

Intrapartum antibiotics for group B streptococcal colonisation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD000115

Identifiers

DOI

10.1586/ERV.11.61

1 reference

24 August 2017

1 reference